Daily dose of beetroot juice helps heart failure patients

A daily dose of beetroot juice significantly improves exercise endurance and blood pressure in older patients with heart failure with preserved ejection fraction, say US researchers.
Source: Nursing Times - Category: Nursing Source Type: news

Related Links:

Biolife4D has achieved a milestone in its ultimate quest to develop human organs for transplant. The company recently announced that it has developed a cardiac patch using a highly specialized 3D printer designed to protect living cells during the printing process. The patch is designed to help patients recover heart function after an acute myocardial infarction, said Ravi Birla, PhD, the company’s chief science officer, in an interview with MD+DI. “Over several weeks, acute myocardial infarction results in scar formation and progresses to chronic heart failure, severely damp...
Source: MDDI - Category: Medical Devices Authors: Tags: 3-D Printing Source Type: news
Catheterization and Cardiovascular Interventions,Volume 92, Issue 4, Page 711-712, October 1, 2018.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research
AbstractThe underlying mechanism for clinical and biochemical manifestations of chronic heart failure (HF) may be due in part to neurohumoral adaptations, such as activation of the renin-angiotensin-aldosterone and sympathetic nervous systems in the periphery and the brain. Internet search and discussion with colleagues are the methods for this study. Since chronic HF is associated with autonomic imbalance with increased sympathetic nerve activity and a withdrawal of parasympathetic activity, it may be considered a brain disease. This phenomenon may be the result of an increased systemic and cerebral angiotensin II signali...
Source: Heart Failure Reviews - Category: Cardiology Source Type: research
Abbott (NYSE:ABT) CEO Miles White may have chosen an eventual successor to take over the corner office, according to a new Forbes report. White, who has been at the head of Abbott for 20 years, named long-time exec Robert Ford as the company’s president and COO, according to the report.The appointment marks the first time an official has served as a number two exec at the company in more than a decade. Ford previously served as exec VP of Abbott’s medtech division, which is now the company’s largest business, Forbes reports. Despite the appointment, which White told analysts was a “succession s...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Featured Abbott Source Type: news
Results from the MOMENTUM-3 trial land FDA approval for the HeartMate 3 left ventricular assist system as long-term destination therapy in heart failure.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure. With the approval, the Chicago-based company said that the device can now be used in patients not eligible for a transplant as a life-long implant. “We partner with physicians to holistically develop therapies that benefit patients and achieve better outcomes. The unique design of the HeartMate 3 LVAD—with its Full MagLev technology—takes an established innovation and improves upon it in meaningful ways to help people with...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news
Advanced heart failure patients who will live with their device for the rest of their life now have access to a heart pump backed by the industry's strongest long-term data HeartMate 3 offers significant advancements for patients, including a pump desig... Devices, Cardiology, FDA Abbott, HeartMate 3, Heart Pump, Left Ventricular Assist Device
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
ConclusionsPulmonic stenosis in FBs is commonly severe and complex, with at least 2 obstructive lesions in most cases, a high incidence of pulmonary trunk hypoplasia and CD, and strong association between prognosis and tricuspid regurgitation severity.
Source: Journal of Veterinary Cardiology - Category: Veterinary Research Source Type: research
Orthopnea is a symptom rather than a condition. It is a shortness of breath that only occurs when a person is lying down and usually subsides when they sit or stand up. Causes include conditions that affect the heart or lungs, such as heart failure or chronic obstructive pulmonary disease (COPD). Learn more here.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Respiratory Source Type: news
- Advanced heart failure patients who will live with their device for the rest of their life now have access to a heart pump backed by the industry's strongest long-term data
Source: Abbott.com - Category: Pharmaceuticals Source Type: news
More News: Beetroot | Cardiology | Heart | Heart Failure | Nurses | Nursing | Sports Medicine